Abiopharma

Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance

REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 2026 Annual Meeting

(70% Positive) STELLA INTERNATIONAL HOLDINGS LTD. (LILAK) Reports Q2 2026 Financial Results

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001918704-26-012429 <b>Size:</b> 1 MB

(30% Negative) BENTLEY SYSTEMS INC (BSY) Reports Q2 2026 Financial Results

(10% Negative) TELEFLEX INC (TFX) Reports Q2 2026 Financial Results

(30% Negative) NEXSTAR MEDIA GROUP, INC. (NXST) Reports Q2 2026 Financial Results

(30% Negative) KORRO BIO, INC. (KRRO) Reports Q2 2026 Financial Results

New Form 424B2 - UBS AG <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001839882-26-023252 <b>Size:</b> 1 MB

(10% Negative) LIGAND PHARMACEUTICALS INC (LGND) Reports Q2 2026 Financial Results

(30% Negative) CULLINAN THERAPEUTICS, INC. (CGEM) Reports Q2 2026 Financial Results

(99% Positive) CREATIVE MEDIA&COMMUNITY TRUST CORPORATION DUAL LISTED (U) Reports Q2 2026 Financial Results

(30% Negative) ARROW ELECTRONICS, INC. (ARW) Reports Q2 2026 Financial Results

New Form DFAN14A - BlackRock ESG Capital Allocation Term Trust <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0000902664-26-002301 <b>Size:</b> 6 MB

(30% Negative) APYX MEDICAL CORP (APYX) Reports Q2 2026 Financial Results